News | February 17, 2023
Biocon Q3 FY23 revenue up 36%
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
With the recent sales force expansion and new product launches, we expect to be back to above-market growth
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Zidavi is recommended by the Infectious Disease Society of America
Subscribe To Our Newsletter & Stay Updated
